Adocia S.A [ADOC] vs Medincell S.A [MEDCL] Detailed Stock Comparison

Adocia S.A

Euronext
Loading...

Medincell S.A

Euronext
Loading...

TLDR: Quick Comparison Summary

Based on 18 vital metrics comparison: Adocia S.A wins in 6 metrics, Medincell S.A wins in 9 metrics, with 0 ties. Medincell S.A appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricAdocia S.AMedincell S.ABetter
P/E Ratio (TTM)-8.38N/AN/A
Price-to-Book Ratio-38.22N/AN/A
Debt-to-Equity Ratio-3.83-4.11Medincell S.A
PEG Ratio-6.30102.70Adocia S.A
EV/EBITDA-22.51-65.76Medincell S.A
Profit Margin (TTM)-76.88%-66.50%Medincell S.A
Operating Margin (TTM)8.14%-17.30%Adocia S.A
EBITDA Margin (TTM)8.14%N/AN/A
Return on Equity301.75%112.65%Adocia S.A
Return on Assets (TTM)-17.81%-10.56%Medincell S.A
Free Cash Flow (TTM)$-15.84M$17.81MMedincell S.A
1-Year Return35.42%37.75%Medincell S.A
Price-to-Sales Ratio (TTM)12.6324.51Adocia S.A
Enterprise Value$155.48M$662.22MMedincell S.A
EV/Revenue Ratio12.8223.88Adocia S.A
Revenue per Share (TTM)$1$1Medincell S.A
Earnings per Share (Diluted)$-1.00$-0.62Medincell S.A
Beta (Stock Volatility)0.351.11Adocia S.A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Adocia S.A vs Medincell S.A Stock Performance Analysis

Loading Price Chart...

Adocia S.A
Medincell S.A
Adocia S.A Stock Overview | Medincell S.A Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Adocia S.A-6.92%-1.14%-12.26%119.10%85.71%21.31%
Medincell S.A2.99%11.14%27.40%28.89%48.12%25.66%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Adocia S.A35.42%140.74%6.85%-89.72%-17.02%-17.02%
Medincell S.A37.75%310.43%222.22%199.86%199.86%199.86%

News Based Sentiment: Adocia S.A vs Medincell S.A

Adocia S.A

News based Sentiment: MIXED

September presented a mixed bag for Adocia, with positive analyst sentiment countered by stock volatility and negative technical indicators. The upcoming earnings release and data presentations are key catalysts, but the overall picture remains uncertain, making it a significant month for investors to assess the company's trajectory.

View Adocia S.A News Sentiment Analysis

Medincell S.A

News based Sentiment: POSITIVE

September was a pivotal month for Medincell, highlighted by promising clinical data for both UZEDY® and Olanzapine LAI, coupled with strategic board appointments and continued investor engagement. These developments reinforce the company’s growth trajectory and position it favorably for future success, making it a significant month for investors.

View Medincell S.A News Sentiment Analysis

Performance & Financial Health Analysis: Adocia S.A vs Medincell S.A

MetricADOCMEDCL
Market Information
Market Cap i€153.13M€656.19M
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i237,346132,874
90 Day Avg. Volume i492,33298,929
Last Close€7.80€22.04
52 Week Range€2.86 - €11.10€12.00 - €22.04
% from 52W High-29.73%0.00%
All-Time High€94.24 (Jul 20, 2015)€22.04 (Sep 23, 2025)
% from All-Time High-91.72%0.00%
Growth Metrics
Quarterly Revenue Growth3.97%3.86%
Quarterly Earnings GrowthN/AN/A
Financial Health
Profit Margin (TTM) i-0.77%-0.67%
Operating Margin (TTM) i0.08%-0.17%
Return on Equity (TTM) i3.02%1.13%
Debt to Equity (MRQ) i-3.83-4.11
Cash & Liquidity
Book Value per Share (MRQ)€-0.20€-0.50
Cash per Share (MRQ)€0.42€2.17
Operating Cash Flow (TTM) i€-15,612,000€19.47M
Levered Free Cash Flow (TTM) i€-11,774,125€4.74M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Adocia S.A vs Medincell S.A

MetricADOCMEDCL
Price Ratios
P/E Ratio (TTM) i-8.38N/A
Forward P/E i-6.30102.70
PEG Ratio i-6.30102.70
Price to Sales (TTM) i12.6324.51
Price to Book (MRQ) i-38.22N/A
Market Capitalization
Market Capitalization i€153.13M€656.19M
Enterprise Value i€155.48M€662.22M
Enterprise Value Metrics
Enterprise to Revenue i12.8223.88
Enterprise to EBITDA i-22.51-65.76
Risk & Other Metrics
Beta i0.351.11
Book Value per Share (MRQ) i€-0.20€-0.50

Financial Statements Comparison: Adocia S.A vs Medincell S.A

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)ADOCMEDCL
Revenue/Sales iN/AN/A
Cost of Goods Sold iN/AN/A
Gross Profit iN/AN/A
Research & Development iN/AN/A
Operating Income (EBIT) iN/AN/A
EBITDA iN/AN/A
Pre-Tax Income iN/AN/A
Income Tax iN/AN/A
Net Income (Profit) iN/AN/A

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)ADOCMEDCL
Cash & Equivalents i€7.53M€59.04M
Total Current Assets i€22.45M€80.62M
Total Current Liabilities i€20.85M€29.87M
Long-Term Debt i€8.57M€51.46M
Total Shareholders Equity i€-3.09M€-16.37M
Retained Earnings i€-9.32M€-18.44M
Property, Plant & Equipment i€3.78M€7.80M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)ADOCMEDCL
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricADOCMEDCL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i237,346132,874
Average Daily Volume (90 Day) i492,33298,929
Shares Outstanding i15.63M33.06M
Float Shares i14.26M24.75M
% Held by Insiders i0.21%0.38%
% Held by Institutions i0.08%0.31%

Dividend Analysis & Yield Comparison: Adocia S.A vs Medincell S.A

MetricADOCMEDCL
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A